Skip to main content
Top
Published in: Current Diabetes Reports 6/2015

01-06-2015 | Psychosocial Aspects (KK Hood and S Jaser, Section Editors)

Treating the Most Vulnerable and Costly in Diabetes

Authors: David V. Wagner, Maggie Stoeckel, Megan E. Tudor, Michael A. Harris

Published in: Current Diabetes Reports | Issue 6/2015

Login to get access

Abstract

Diabetic ketoacidosis (DKA) is associated with negative health outcomes and high costs for patients, families, and communities. Interventions developed to effectively reduce DKA and related costs should target the multiple risk factors associated with DKA and adherence difficulties. Certain demographic, psychological, and family factors are associated with increased risk for adherence problems and DKA. Individuals with a combination of risk factors (e.g., mental health problems, low socioeconomic status, high family conflict) may be particularly vulnerable to DKA. Although several different interventions have demonstrated promise in improving adherence and/or decreasing the risk of DKA, the generalizability of treatment results to those individuals most vulnerable to DKA is limited. Approaches which include multiple evidence-based components of care, are flexible in treatment delivery (e.g., home- and community-based, utilize technology), and target the multiple risk factors across relevant systems (e.g., individual, family, school, medical) are warranted to effectively reduce DKA in vulnerable populations.
Literature
2.
go back to reference Kennan HT, Foster CM, Bratton SL. Social factors associated with prolonged hospitalization among diabetic children. Pediatrics. 2002;109:40–4.CrossRef Kennan HT, Foster CM, Bratton SL. Social factors associated with prolonged hospitalization among diabetic children. Pediatrics. 2002;109:40–4.CrossRef
3.
go back to reference Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta: US Department of Health and Human Services; 2014. p. 2014. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta: US Department of Health and Human Services; 2014. p. 2014.
4.•
go back to reference Tieder JS, McLeod L, Keren R, Luan X, Localio R, Mahant S, et al. Variation in resource use and readmission for diabetic ketoacidosis in children’s hospitals. Pediatrics. 2013;132:229–36. This reference is important in that it characterizes the significant financial resources devoted to hospitalizations for repeat DKA in youth.CrossRefPubMed Tieder JS, McLeod L, Keren R, Luan X, Localio R, Mahant S, et al. Variation in resource use and readmission for diabetic ketoacidosis in children’s hospitals. Pediatrics. 2013;132:229–36. This reference is important in that it characterizes the significant financial resources devoted to hospitalizations for repeat DKA in youth.CrossRefPubMed
5.
go back to reference Javor KA, Kotsanos JG, McDonald RC, Baron AD, Kesterson JG, Tierney WM. Diabetic ketoacidosis charges relative to medical charges of adult patients with type 1 diabetes. Diabetes Care. 1997;20:349–54.CrossRefPubMed Javor KA, Kotsanos JG, McDonald RC, Baron AD, Kesterson JG, Tierney WM. Diabetic ketoacidosis charges relative to medical charges of adult patients with type 1 diabetes. Diabetes Care. 1997;20:349–54.CrossRefPubMed
6.
go back to reference Agency for Healthcare Research and Quality. Databases and related tools from the healthcare cost and utilization project (HCUP) [article online]. National Center for Health Statistics, Centers for Disease Control. Available from www.hcup-us.ahrq.gov/reports/statbriefs. Agency for Healthcare Research and Quality. Databases and related tools from the healthcare cost and utilization project (HCUP) [article online]. National Center for Health Statistics, Centers for Disease Control. Available from www.​hcup-us.​ahrq.​gov/​reports/​statbriefs.
7.
8.
go back to reference Kurtz SMS. Adherence to diabetes regimens: empirical status and clinical applications. Diabetes Educ. 1990;16:50–6.CrossRefPubMed Kurtz SMS. Adherence to diabetes regimens: empirical status and clinical applications. Diabetes Educ. 1990;16:50–6.CrossRefPubMed
10.
go back to reference Harris MA, Hood KK, Weissberg-Benchell J. Teens with diabetes: a clinician’s guide. Alexandria: American Diabetes Association; 2014. Harris MA, Hood KK, Weissberg-Benchell J. Teens with diabetes: a clinician’s guide. Alexandria: American Diabetes Association; 2014.
11.
go back to reference Gill G, Nayak AU, Wilkins J, Hankey J, Raffeeq P, Varughese GI, et al. Challenges of emerging adulthood-transition from paediatric to adult diabetes. World J Diabetes. 2014;15:630–5.CrossRef Gill G, Nayak AU, Wilkins J, Hankey J, Raffeeq P, Varughese GI, et al. Challenges of emerging adulthood-transition from paediatric to adult diabetes. World J Diabetes. 2014;15:630–5.CrossRef
12.
go back to reference Charron-Prochownik D, Kovacs M, Obrosky DS, Stiffler L. Biomedical and psychosocial predictors of early rehospitalization among children with insulin-dependent diabetes mellitus: a longitudinal study. Diabetes Med. 1994;11:372–7.CrossRef Charron-Prochownik D, Kovacs M, Obrosky DS, Stiffler L. Biomedical and psychosocial predictors of early rehospitalization among children with insulin-dependent diabetes mellitus: a longitudinal study. Diabetes Med. 1994;11:372–7.CrossRef
13.
go back to reference Randall L, Begovic J, Hudson M, Smiley D, Peng L, Pitre N, et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care. 2011;34:1891–6.CrossRefPubMedCentralPubMed Randall L, Begovic J, Hudson M, Smiley D, Peng L, Pitre N, et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care. 2011;34:1891–6.CrossRefPubMedCentralPubMed
14.
go back to reference La Greca AM, Swales T, Klemp S, Madigan S, Skler J. Adolescents with diabetes: gender differences in psychosocial and glycemic control. Children’s Health Care. 1995;24:61–78.CrossRef La Greca AM, Swales T, Klemp S, Madigan S, Skler J. Adolescents with diabetes: gender differences in psychosocial and glycemic control. Children’s Health Care. 1995;24:61–78.CrossRef
15.
go back to reference Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med. 2002;32:235–47.CrossRefPubMed Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med. 2002;32:235–47.CrossRefPubMed
16.
go back to reference Piette JD, Richardson C, Valenstein M. Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression. Am J Manag Care. 2004;10:152–62.PubMed Piette JD, Richardson C, Valenstein M. Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression. Am J Manag Care. 2004;10:152–62.PubMed
17.
go back to reference Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complicat. 2005;19:113–22.PubMed Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complicat. 2005;19:113–22.PubMed
18.
go back to reference Kitabchi AE, Nyenwe EA. Hyperglycemic crises in diabetes mellitus: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin N Am. 2006;35:725–51.CrossRef Kitabchi AE, Nyenwe EA. Hyperglycemic crises in diabetes mellitus: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin N Am. 2006;35:725–51.CrossRef
19.
go back to reference Harris MA, Spiro K, Heywood M, Wagner D, Hoehn D, Hatten A, et al. Piloting intensive behavioral health for youth with type 1 diabetes: avoiding avoidable hospitalizations [Abstract]. Diabetes. 2013;73:827-P. Harris MA, Spiro K, Heywood M, Wagner D, Hoehn D, Hatten A, et al. Piloting intensive behavioral health for youth with type 1 diabetes: avoiding avoidable hospitalizations [Abstract]. Diabetes. 2013;73:827-P.
20.
go back to reference Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–8.CrossRefPubMed Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–8.CrossRefPubMed
21.
go back to reference Lancaster BM, Gadaire DM, Holman K, LeBlanc LA. Association between diabetes treatment adherence and parent–child agreement regarding treatment responsibilities. Fam Syst Health. 2015. doi:10.1037/fsh0000092.PubMed Lancaster BM, Gadaire DM, Holman K, LeBlanc LA. Association between diabetes treatment adherence and parent–child agreement regarding treatment responsibilities. Fam Syst Health. 2015. doi:10.​1037/​fsh0000092.PubMed
22.
go back to reference Hilliard ME, Wu YP, Rausch J, Dolan LM, Hood KK. Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. J Adolesc Health. 2013;52:28–34.CrossRefPubMed Hilliard ME, Wu YP, Rausch J, Dolan LM, Hood KK. Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. J Adolesc Health. 2013;52:28–34.CrossRefPubMed
23.
go back to reference Cohen DM, Lumley MA, Naar-King S, Partridge T, Cakan N. Child behavior problems and family functioning as predictors of adherence and glycemic control in economically disadvantaged children with type 1 diabetes: a prospective study. J Pediatr Psychol. 2004;29:171–84.CrossRefPubMed Cohen DM, Lumley MA, Naar-King S, Partridge T, Cakan N. Child behavior problems and family functioning as predictors of adherence and glycemic control in economically disadvantaged children with type 1 diabetes: a prospective study. J Pediatr Psychol. 2004;29:171–84.CrossRefPubMed
24.
go back to reference Jacobson AM, Hauser ST, Lavori P, Willett JB, Cole CF, Wolfsdorf JI, et al. Family environment and glycemic control: a four-year prospective study of children and adolescents with insulin-dependent diabetes mellitus. Psychosom Med. 1994;56:401–9.CrossRefPubMed Jacobson AM, Hauser ST, Lavori P, Willett JB, Cole CF, Wolfsdorf JI, et al. Family environment and glycemic control: a four-year prospective study of children and adolescents with insulin-dependent diabetes mellitus. Psychosom Med. 1994;56:401–9.CrossRefPubMed
25.
go back to reference Hoey H. Psychosocial factors are associated with metabolic control in adolescents: research from the Hvidoere Study Group on Childhood Diabetes. Pediatr Diabetes. 2009;10:9–14.CrossRefPubMed Hoey H. Psychosocial factors are associated with metabolic control in adolescents: research from the Hvidoere Study Group on Childhood Diabetes. Pediatr Diabetes. 2009;10:9–14.CrossRefPubMed
26.••
go back to reference Hood KK, Rohan JM, Peterson CM, Drotar D. Interventions with adherence-promoting components in pediatric type 1 diabetes. Diabetes Care. 2010;33:1658–64. This review of adherence-promoting literature highlights the importance of multicomponent interventions.CrossRefPubMedCentralPubMed Hood KK, Rohan JM, Peterson CM, Drotar D. Interventions with adherence-promoting components in pediatric type 1 diabetes. Diabetes Care. 2010;33:1658–64. This review of adherence-promoting literature highlights the importance of multicomponent interventions.CrossRefPubMedCentralPubMed
27.
go back to reference Tsiouli E, Alexopoulos EC, Stefanaki C, Darviri C, Chrousos GP. Effects of diabetes-related family stress on glycemic control in young patients with type 1 diabetes. Can Fam Physician. 2013;59:143–9.PubMedCentralPubMed Tsiouli E, Alexopoulos EC, Stefanaki C, Darviri C, Chrousos GP. Effects of diabetes-related family stress on glycemic control in young patients with type 1 diabetes. Can Fam Physician. 2013;59:143–9.PubMedCentralPubMed
28.
go back to reference Hoey H, Aanstoot HJ, Chiareli F, et al. Good metabolic control is associated with better quality of life in 2,101 adolescent with type 1 diabetes. Diabetes Care. 2001;24:1923–8.CrossRefPubMed Hoey H, Aanstoot HJ, Chiareli F, et al. Good metabolic control is associated with better quality of life in 2,101 adolescent with type 1 diabetes. Diabetes Care. 2001;24:1923–8.CrossRefPubMed
29.
go back to reference Cameron FJ, Skinner TC, de Beaufort CE, et al. Are family factors universally related to metabolic outcomes in adolescents with type 1 diabetes? Diabet Med. 2008;25:463–8.CrossRefPubMed Cameron FJ, Skinner TC, de Beaufort CE, et al. Are family factors universally related to metabolic outcomes in adolescents with type 1 diabetes? Diabet Med. 2008;25:463–8.CrossRefPubMed
30.
go back to reference Swift EE, Chen R, Hershberger A, Holmes CS. Demographic risk factors, mediator, and moderators in youths’ diabetes metabolic control. Ann Behav Med. 2006;32:355–65. Swift EE, Chen R, Hershberger A, Holmes CS. Demographic risk factors, mediator, and moderators in youths’ diabetes metabolic control. Ann Behav Med. 2006;32:355–65.
31.
go back to reference Geffken GR, Lewis C, Johnson SB, Silverstein JH, Rosenbloom AL, Monaco L. Residential treatment for youngsters with difficult-to-manage insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab. 1997;10:517–27.CrossRefPubMed Geffken GR, Lewis C, Johnson SB, Silverstein JH, Rosenbloom AL, Monaco L. Residential treatment for youngsters with difficult-to-manage insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab. 1997;10:517–27.CrossRefPubMed
32.
go back to reference Golden MP, Herrold AJ, Orr DP. An approach to prevention of recurrent diabetic ketoacidosis in the pediatric population. J Pediatr. 1985;107:195–200.CrossRefPubMed Golden MP, Herrold AJ, Orr DP. An approach to prevention of recurrent diabetic ketoacidosis in the pediatric population. J Pediatr. 1985;107:195–200.CrossRefPubMed
33.
go back to reference Bloomgarden ZT, Karmally W, Metzger MJ, Brothers M, Nechemias C, Bookman J, et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care. 1987;10:263–72.CrossRefPubMed Bloomgarden ZT, Karmally W, Metzger MJ, Brothers M, Nechemias C, Bookman J, et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care. 1987;10:263–72.CrossRefPubMed
34.
go back to reference Giordano B, Rosenbloom AL, Heller D, Weber FT, Gonzalez R, Grgic A. Regional services for children and youth with diabetes. Pediatrics. 1977;60:492–8. Giordano B, Rosenbloom AL, Heller D, Weber FT, Gonzalez R, Grgic A. Regional services for children and youth with diabetes. Pediatrics. 1977;60:492–8.
35.
go back to reference Grey M, Boland EA, Davidson M, Li J, Tamborlane WV. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr. 2000;137:107–13.CrossRefPubMed Grey M, Boland EA, Davidson M, Li J, Tamborlane WV. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr. 2000;137:107–13.CrossRefPubMed
36.••
go back to reference Stanger C, Ryan SR, Delhey LM, Thrailkill K, Li Z, Li Z, et al. A multicomponent motivational intervention to improve adherence among adolescents with poorly controlled type 1 diabetes: a pilot study. J Pediatr Psychol. 2013;38:629–37. This is another reference supporting the significance of multicomponent approaches to improving adherence in type 1 diabetes.CrossRefPubMedCentralPubMed Stanger C, Ryan SR, Delhey LM, Thrailkill K, Li Z, Li Z, et al. A multicomponent motivational intervention to improve adherence among adolescents with poorly controlled type 1 diabetes: a pilot study. J Pediatr Psychol. 2013;38:629–37. This is another reference supporting the significance of multicomponent approaches to improving adherence in type 1 diabetes.CrossRefPubMedCentralPubMed
37.
go back to reference Wysocki T, Greco P, Harris MA, Bubb J, White NH. Behavior therapy for families of adolescents with diabetes: maintenance of treatment effects. Diabetes Care. 2001;24:441–4.CrossRefPubMed Wysocki T, Greco P, Harris MA, Bubb J, White NH. Behavior therapy for families of adolescents with diabetes: maintenance of treatment effects. Diabetes Care. 2001;24:441–4.CrossRefPubMed
38.
go back to reference Wysocki T, Harris MA, Buckloh LM, et al. Effects of behavioral family systems therapy for diabetes on adolescents’ family relationships, treatment adherence and metabolic control. J Pediatr Psychol. 2006;31:928–38.CrossRefPubMed Wysocki T, Harris MA, Buckloh LM, et al. Effects of behavioral family systems therapy for diabetes on adolescents’ family relationships, treatment adherence and metabolic control. J Pediatr Psychol. 2006;31:928–38.CrossRefPubMed
39.
go back to reference Ellis DA, Frey MA, Naar-King S, Templin T, Cunningham P, Cakan N. Use of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: a randomized controlled trial. Diabetes Care. 2005;28:1604–10.CrossRefPubMed Ellis DA, Frey MA, Naar-King S, Templin T, Cunningham P, Cakan N. Use of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: a randomized controlled trial. Diabetes Care. 2005;28:1604–10.CrossRefPubMed
40.
go back to reference Ellis D, Naar-King S, Templin T, Frey M, Cunningham P, Sheidow A, et al. Multisystemic therapy for adolescents with poorly controlled type 1 diabetes: reduced diabetic ketoacidosis admissions and related costs over 24 months. Diabetes Care. 2008;31:1746–7.CrossRefPubMedCentralPubMed Ellis D, Naar-King S, Templin T, Frey M, Cunningham P, Sheidow A, et al. Multisystemic therapy for adolescents with poorly controlled type 1 diabetes: reduced diabetic ketoacidosis admissions and related costs over 24 months. Diabetes Care. 2008;31:1746–7.CrossRefPubMedCentralPubMed
41.
go back to reference Harris MA, Spiro K, Heywood M, et al. Novel interventions in children’s health care (NICH): innovative treatment for youth with complex medical conditions. Clin Pract Pediatr Psychol. 2013;1:137–45.CrossRef Harris MA, Spiro K, Heywood M, et al. Novel interventions in children’s health care (NICH): innovative treatment for youth with complex medical conditions. Clin Pract Pediatr Psychol. 2013;1:137–45.CrossRef
42.••
go back to reference Harris MA, Wagner DV, Heywood M, Hoehn D, Bahia H, Spiro K. Youth repeatedly hospitalized for DKA: proof of concept for Novel Interventions in Children’s Healthcare (NICH). Diabetes Care. 2014;37:e125–6. This reference describes an example of a treatment approach specifically tailored to the needs of youth at risk for repeat DKA.CrossRefPubMed Harris MA, Wagner DV, Heywood M, Hoehn D, Bahia H, Spiro K. Youth repeatedly hospitalized for DKA: proof of concept for Novel Interventions in Children’s Healthcare (NICH). Diabetes Care. 2014;37:e125–6. This reference describes an example of a treatment approach specifically tailored to the needs of youth at risk for repeat DKA.CrossRefPubMed
43.
go back to reference Harris MA, Spiro K, Heywood M, Hatten A, Hoehn D, Wagner D. Intensive behavioral health for youth repeatedly hospitalized for DKA: NICH work. [Abstract]. Diabetes. 2013;2013:73. Harris MA, Spiro K, Heywood M, Hatten A, Hoehn D, Wagner D. Intensive behavioral health for youth repeatedly hospitalized for DKA: NICH work. [Abstract]. Diabetes. 2013;2013:73.
44.
go back to reference Shea S, Weinstock RS, Starren J, Teresi J, Palmas W, Field L, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc. 2006;13:40–51.CrossRefPubMedCentralPubMed Shea S, Weinstock RS, Starren J, Teresi J, Palmas W, Field L, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc. 2006;13:40–51.CrossRefPubMedCentralPubMed
45.
go back to reference Malasanos TH, Burlingame JB, Youngblade L, Patel BD, Muir AB. Improved access to subspecialist diabetes care by telemedicine: cost savings and care measures in the first two years of the FITE diabetes project. J Telemed Telecare. 2005;11:74–6.CrossRefPubMed Malasanos TH, Burlingame JB, Youngblade L, Patel BD, Muir AB. Improved access to subspecialist diabetes care by telemedicine: cost savings and care measures in the first two years of the FITE diabetes project. J Telemed Telecare. 2005;11:74–6.CrossRefPubMed
46.
go back to reference Franklin VL, Waller A, Pagliari C, Greene SA. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med. 2006;23:1332–8.CrossRefPubMed Franklin VL, Waller A, Pagliari C, Greene SA. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med. 2006;23:1332–8.CrossRefPubMed
47.
go back to reference Harris MA, Freeman KA, Duke D C, Hirschfield B, Boston B. Can you hear (and see) me now?: Skype-based intervention for teens with poorly controlled diabetes [Abstract]. Diabetes 2012;72:345-OR. Harris MA, Freeman KA, Duke D C, Hirschfield B, Boston B. Can you hear (and see) me now?: Skype-based intervention for teens with poorly controlled diabetes [Abstract]. Diabetes 2012;72:345-OR.
48.
go back to reference Grey M, Whittemore R, Jeon S, Murphy K, Faulkner MS, Delamater A. Internet psycho education programs improve outcomes in youth with type 1 diabetes. Diabetes Care. 2013;36:2475–82.CrossRefPubMedCentralPubMed Grey M, Whittemore R, Jeon S, Murphy K, Faulkner MS, Delamater A. Internet psycho education programs improve outcomes in youth with type 1 diabetes. Diabetes Care. 2013;36:2475–82.CrossRefPubMedCentralPubMed
49.
50.
go back to reference Borus JS, Laffel L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010;22:405–11.CrossRefPubMedCentralPubMed Borus JS, Laffel L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010;22:405–11.CrossRefPubMedCentralPubMed
Metadata
Title
Treating the Most Vulnerable and Costly in Diabetes
Authors
David V. Wagner
Maggie Stoeckel
Megan E. Tudor
Michael A. Harris
Publication date
01-06-2015
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 6/2015
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-015-0606-5

Other articles of this Issue 6/2015

Current Diabetes Reports 6/2015 Go to the issue

Diabetes, Other Diseases, and New Complications: Emerging Associations (JJ Nolan, Section Editor)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

The Forgotten Role of Glucose Effectiveness in the Regulation of Glucose Tolerance

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Does Nutrient Sensing Determine How We “See” Food?

Health Care Delivery Systems and Implementation in Diabetes (EB Morton-Eggleston, Section Editor)

Diabetes Self-Management Interventions for Adults with Type 2 Diabetes Living in Rural Areas: A Systematic Literature Review

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Ambient Air Pollution: An Emerging Risk Factor for Diabetes Mellitus

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.